Related Experiment Video
Updated: Nov 15, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Risk Perception Among a Lung Cancer Screening Population
Jane Turner1, Gregory R Pond1, Alain Tremblay2
1McMaster University, Hamilton, ON, Canada.
Lung cancer risk perception aligns with calculated risk in screening participants. Focusing on factors influencing risk perception, rather than worry, may improve lung cancer screening program engagement.
Area of Science:
- Pulmonology
- Oncology
- Public Health
Background:
- Lung cancer screening programs require high-risk, willing participants.
- Patient risk perception influences engagement with screening and smoking cessation.
- Understanding risk perception is key for effective lung cancer screening initiatives.
Purpose of the Study:
- Identify factors associated with lung cancer risk perception.
- Examine the link between perceived and calculated lung cancer risk.
- Assess the relationship between risk perception and smoking cessation intent.
Main Methods:
- Analysis of data from the Pan-Canadian Early Detection of Lung Cancer (PanCan) Study.
- Recruitment of current/former smokers aged 50-75 with at least 2% 6-year lung cancer risk.
- Use of baseline questionnaires for risk perception and worry, with cumulative logistic regression.
Main Results:
- Higher perceived lung cancer risk correlated positively with calculated risk (P=.032).
- Factors like younger age, former smoker status, respiratory symptoms, lower FEV1, COPD, and family history were linked to higher perceived risk.
- Risk perception, but not calculated risk, showed a positive association with lung cancer worry and intent to quit smoking.
Conclusions:
- Individual lung cancer risk perception correlates with calculated risk in a screening population.
- Lung cancer screening awareness efforts may be more effective by targeting factors associated with higher risk perception.
- Leveraging patient worry may be less impactful for screening program promotion than addressing risk perception directly.
Related Concept Videos
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Radiological Investigation II: MRI and Ventilation Perfusion Scan
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Statistical Methods for Analyzing Epidemiological Data
Cancer Prevention
Some...

